This site is intended for healthcare professionals only
LoginRegister
GSK buys IDRx for up to USD 1.15 billionDiabetes treatment: Lupin buys Huminsulin from Eli Lilly
JnJ launches Shockwave Javelin Peripheral IVL Catheter in EuropeEuropean Commission approves Janssen-Cilag International Rybrevant, Lazcluze combo for first-line...
PfizerPfizer ceases development of Hemophilia A gene therapy Giroctocogene Fitelparvovec
Eli Lilly gets USFDA Breakthrough Therapy designation for olomorasib with Keytruda for lung cancerCDSCO Panel Approves Eli Lilly's Protocol Amendment Proposal for Mirikizumab study
Zydus Asked to Revise Phase III Trial Protocol for Cough Syrup FDC After CDSCO Panel ReviewCDSCO Panel rejects Zydus Healthcare's proposal to waive Phase III CT of Diphenhydramine,...
Karnataka: HCKarnataka HC Stays Action Against Pharma Firms Producing Nutraceuticals in Drug Facilities
Racket manufacturing fake medicines busted, factory owner heldDelhi: Woman arrested for illegally selling Mephentermine injections to gym goers
Govt Allows Stickering, Orders New MRPs Post GST Reduction, AiMeD Welcomes DirectiveZydus Wellness subsidiary receives GST demand of Rs 56.33 crore
Reliance buys Karkinos Healthcare for Rs 375 croreReliance buys Karkinos Healthcare for Rs 375 crore
Eli Lilly gets USFDA Breakthrough Therapy designation for olomorasib with Keytruda for lung cancerCDSCO Panel Approves Eli Lilly's Protocol Amendment Proposal for Antidiabetic Drug Retatrutide study
Lupin Manufacturing Solutions: Empagliflozin API gets CADIFA approval from ANVISA, BrazilSubmit justification for dose assumption and animal toxicity data: CDSCO Panel Tells Lupin on...
AstraZeneca Gets SEC Approval to Conduct Phase IV Trial of Hyperkalemia Drug Sodium Zirconium CyclosilicateCDSCO Panel Approves AstraZeneca's Protocol Amendment Proposal To Study antihypertensive drug...
X